Dr. Fumiko Chino

Could cuts to federal cancer research funding slow new treatments and clinical trials? Dr. Fumiko Chino, MD, FASCO, joins Christopher Hensley to explain how NIH and National Cancer Institute investments move discoveries from the laboratory into patient care—and why today’s funding choices can shape cancer outcomes for decades. The conversation explores clinical trials, survivorship, rural and underserved access, medical debt, financial toxicity, and the economic return created by sustained research. Dr. Chino also shares how personal loss inspired her mission to improve cancer care, affordability, quality, and access.